We have also recently reported functional residual MCT1 and MCT4 expression in different BSG-null cancer cell lines [134, 14], suggesting the presence of unidentified proteins or mechanisms for targeting these MCTs to the cell surface. The gene discussed is BSG; the disease is cancer.